p.krastev
TL2 Moderator · Lyon
Contributes reviews on supplier material. Based in Lyon.
Joined 6 April 2025 · last posted 8d
104 posts, newest first. Showing up to 150.
-
How shortages have affected compounding permissions Replied, post #55 · Access › Shortages · 20 Jul 2026 · 6 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
Immortal time bias in a claims-database study — one year on Replied, post #33 · Evidence › Study critique · 20 Jul 2026 · 21 likes I read post #31 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Deletion sequences: expected mass shifts by residue — the long version Replied, post #17 · Analytics › Impurities & related substances · 20 Jul 2026 · 10 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #70 · Evidence › Journal club · 19 Jul 2026 · 30 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
[2026 update] Journal club: what we got wrong in an earlier session Replied, post #6 · Evidence › Journal club · 10 Jul 2026 · 12 likes Picking up post #3: that is the part I would want checked first. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence…
-
Revisiting: What pooling buys you and what it destroys Replied, post #53 · Evidence › Meta-analyses · 13 Jun 2026 · 6 likes Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A…
-
GLP-1 receptor distribution: central and peripheral Replied, post #61 · Pharmacology › Receptor biology · 2 Jun 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Historical amylin analogues and what happened to them Replied, post #14 · Compounds › Cagrilintide & amylin analogues · 1 Jun 2026 · 0 likes What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is durable with continued use, whether satiety adaptation occurs…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #34 · Analytics › HPLC & UHPLC · 29 May 2026 · 19 likes I read post #32 twice before replying, because I had assumed the opposite. Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary…
-
Tracking intake honestly when appetite is absent Replied, post #40 · Nutrition & Training › Protein & intake · 28 May 2026 · 0 likes This follows post #37 rather than contradicting it. Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as satiating as…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #29 · Analytics › Home & field testing · 24 May 2026 · 32 likes post #28 is right about the mechanism and I think understates the practical bit. Enzyme assays: if you have an enzyme that reacts specifically with your compound, an…
-
An 18-month record including the parts that went badly Replied, post #19 · Outcomes › Progress reports · 18 May 2026 · 0 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
-
Spreadsheets: an appreciation — what changed since Replied, post #45 · Lounge › Off topic · 17 May 2026 · 23 likes On post #41 — agreed on the reasoning, with one qualification. Science communication: if you come across an interesting science paper or article about peptides or…
-
The most useful thing you learned here that was not the answer you came for Replied, post #40 · Lounge › Off topic · 6 May 2026 · 1 like Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #5 · Analytics › COA interpretation · 28 Apr 2026 · 3 likes Worth separating two things that the opening post runs together. A certificate of analysis is a statement by its issuer that a defined test was performed on a defined…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #24 · Clinical › Bloodwork · 22 Apr 2026 · 11 likes Coming back to post #22, because the follow-up matters more than the original answer. Reference intervals: constructed to contain the central 95% of a reference…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #18 · Devices › Syringes & needles · 18 Apr 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #43 · Practice › Interactions · 6 Apr 2026 · 0 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #56 · Data & Tools › Calculators · 1 Apr 2026 · 10 likes post #55 is right about the mechanism and I think understates the practical bit. Precision and significant figures: the calculators do not round to match your input…
-
Grapefruit: why this class is not the class that cares Replied, post #90 · Practice › Interactions · 28 Mar 2026 · 13 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #35 · Practice › Administration · 24 Mar 2026 · 8 likes Coming back to post #33, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #17 · Meta › Announcements · 16 Mar 2026 · 10 likes Coming back to post #15, because the follow-up matters more than the original answer. Staff announcements, policy changes, and scheduled maintenance. Read-only except…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #13 · Compounds › Repair & healing peptides · 8 Mar 2026 · 2 likes post #12 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Coming back to: Time to steady state after a dose increase Replied, post #9 · Pharmacology › Pharmacokinetics · 4 Mar 2026 · 1 like Worth separating two things that post #5 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Measurement error in a self-reported exposure Replied, post #70 · Evidence › Study critique · 25 Feb 2026 · 16 likes Coming back to post #68, because the follow-up matters more than the original answer. What makes a methodological criticism substantive: it identifies a specific…
-
Choosing which test to pay for, given a fixed budget Replied, post #5 · Sourcing › Independent verification · 24 Feb 2026 · 0 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #16 · Compounds › Cagrilintide & amylin analogues · 20 Feb 2026 · 0 likes On post #12 — agreed on the reasoning, with one qualification. Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are…
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #14 · Compounds › Secretagogues & GH axis · 16 Feb 2026 · 27 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
-
Coming back to: Pen dose counters: what a click does and does not guarantee Replied, post #5 · Devices › Pens & autoinjectors · 11 Feb 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #22 · Compounds › Semaglutide · 7 Feb 2026 · 16 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Guidelines revision: what changed and why — one year on Replied, post #67 · Meta › Announcements · 6 Feb 2026 · 11 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope.
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #16 · Clinical › Comorbidities · 3 Feb 2026 · 0 likes Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute…
-
Trifluoroacetate content and its consequences Replied, post #41 · Analytics › Impurities & related substances · 29 Jan 2026 · 17 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
-
Revisiting: Absolute versus relative contraindications Replied, post #15 · Safety › Contraindications · 28 Jan 2026 · 17 likes Picking up post #12: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
What a stability-indicating method is and how you demonstrate one Replied, post #3 · Analytics › Method validation · 13 Jan 2026 · 5 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
Follow-up: Search filters: what is missing Replied, post #12 · Meta › Site feedback · 10 Jan 2026 · 0 likes Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible to you, report it. Accessibility matters.
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #6 · Outcomes › Body composition · 8 Jan 2026 · 0 likes On post #2 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #39 · Compounds › Other compounds · 31 Dec 2025 · 31 likes Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
-
Early satiety becoming a problem rather than a benefit Replied, post #19 · Practice › Side effects · 25 Dec 2025 · 0 likes This follows post #16 rather than contradicting it. Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #26 · Research Methods › N-of-1 designs · 10 Dec 2025 · 29 likes This follows post #23 rather than contradicting it. Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures…
-
Pen dose counters: what a click does and does not guarantee Replied, post #96 · Devices › Pens & autoinjectors · 19 Nov 2025 · 0 likes Reusability: some pens are single-use (throw away after one injection). Others can be reused until empty. Confirm which type you have. Reusing a single-use pen is…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #15 · Devices › Pens & autoinjectors · 10 Nov 2025 · 0 likes Injection duration: most pens deliver the dose over several seconds. Holding the button down for the full duration ensures complete delivery. Releasing early can result…
-
Titles that describe the question, not the situation Replied, post #142 · Start Here › How to Ask · 6 Nov 2025 · 5 likes Coming back to post #140, because the follow-up matters more than the original answer. Disagreement-style questions: "I read this and it contradicts what I heard here,…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #41 · Compounds › Tirzepatide · 20 Oct 2025 · 2 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Sleep tracking data and its considerable limitations Replied, post #36 · Wellbeing › Sleep · 19 Oct 2025 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #9 · Research Methods › N-of-1 designs · 2 Oct 2025 · 24 likes Coming back to post #7, because the follow-up matters more than the original answer. Statistical analysis of n-of-1 data: comparing before versus after with a t-test or…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #105 · Compounds › Oral incretins · 20 Sep 2025 · 13 likes Coming back to post #103, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Temperature loggers worth the money Replied, post #30 · Devices › Cold chain · 15 Sep 2025 · 21 likes Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque containers reduce light exposure. For short-term storage, keeping the vial in its…
-
Payment method and the leverage it gives you, ranked Replied, post #5 · marked as the solution · Sourcing › Payments · 13 Sep 2025 · 7 likes Documentation and tax implications: payments you make for compounds might have implications for tax reporting depending on your jurisdiction. Keeping clear records…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #95 · Data & Tools › Datasets · 10 Sep 2025 · 4 likes Bias toward positive outcomes: datasets collected by members are biased toward people who found the compounds useful. People who did not respond do not return. People…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #74 · Data & Tools › Datasets · 9 Sep 2025 · 24 likes I read post #72 twice before replying, because I had assumed the opposite. Community-collected datasets: some members have compiled datasets from their own experience…
-
How to research a compound with no human data without deceiving yourself Replied, post #95 · Compounds › Other compounds · 4 Aug 2025 · 0 likes Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite. The documented adverse profile includes blood pressure elevation…
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #42 · Compounds › Cagrilintide & amylin analogues · 17 Jul 2025 · 0 likes The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The pharmacokinetics are the reason the dosing schedule makes sense.
-
EU-wide position versus national implementation Replied, post #18 · Regional › European Union · 16 Jul 2025 · 8 likes Coming back to post #16, because the follow-up matters more than the original answer. Germany: BfArM implements EU framework. Statutory insurance (the majority)…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #87 · Wellbeing › Mental health · 11 Jul 2025 · 22 likes post #86 answers the question as asked. The question underneath it is different. Disordered eating history: a history of anorexia, bulimia, or other eating disorders…
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #32 · Analytics › Mass spectrometry · 8 Jul 2025 · 25 likes This follows post #29 rather than contradicting it. Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #22 · Practice › Reconstitution · 8 Jul 2025 · 2 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
A report I filed that turned out to be wrong, and the correction Replied, post #131 · Sourcing › Vendor reports · 1 Jul 2025 · 17 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #124 · Clinical › Comorbidities · 25 Jun 2025 · 0 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #144 · Practice › Reconstitution · 24 Jun 2025 · 33 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #47 · Regional › UK & Ireland · 21 Jun 2025 · 14 likes Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions and specialist service availability. Postcode determines…
-
Coming back to: When "no data" is the complete and final answer Replied, post #6 · Compounds › Other compounds · 5 Jun 2025 · 1 like When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #38 · Compounds › Oral incretins · 27 May 2025 · 0 likes post #37 answers the question as asked. The question underneath it is different. Orforglipron is a small molecule, not a peptide. That changes almost everything: no…
-
Half-life, steady state, and accumulation worked through Replied, post #16 · Pharmacology › Pharmacokinetics · 23 May 2025 · 11 likes SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises gastric pH and promotes absorption. Without it, oral…
-
Reading a trial's population section before its results — does this still hold? Replied, post #133 · Evidence › Trials · 22 May 2025 · 1 like Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #109 · Compounds › Semaglutide · 8 May 2025 · 14 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Antibiotics and a course of something with delayed emptying Replied, post #33 · Practice › Interactions · 3 May 2025 · 0 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
Adjudicated events and why the definition matters — the long version Replied, post #120 · Evidence › Trials · 26 Apr 2025 · 32 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Reading an MS report that only gives you a single number Replied, post #55 · Analytics › Mass spectrometry · 17 Apr 2025 · 17 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Requesting a page: what makes a good request Replied, post #51 · Documentation › Wiki requests · 9 Apr 2025 · 16 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
-
UK access routes, dated and sourced — a second dataset Replied, post #57 · Regional › UK & Ireland · 30 Mar 2025 · 0 likes Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate.…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #129 · Access › International · 28 Mar 2025 · 16 likes I read post #127 twice before replying, because I had assumed the opposite. Regulatory position dates: a regulatory position is only current as of when it was written.…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #13 · Sourcing › Vendor reports · 22 Mar 2025 · 5 likes Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back.…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #41 · Analytics › Mass spectrometry · 21 Mar 2025 · 14 likes Coming back to post #39, because the follow-up matters more than the original answer. Sample matrix effects: if a sample is dissolved in a complex matrix, other…
-
Maintainer handover: how it works Replied, post #54 · Meta › Wiki maintenance · 17 Mar 2025 · 17 likes Outdated external links: if a maintained page links to external sources and those links are broken or pages have moved, reporting that helps keep the page current.
-
Journal club: SURMOUNT-1, read without the press release Replied, post #72 · Evidence › Journal club · 6 Mar 2025 · 0 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #131 · Sourcing › Regulatory · 5 Mar 2025 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A promotion I argued against, and why I lost Replied, post #110 · Documentation › Doc review · 24 Feb 2025 · 32 likes post #109 is right about the mechanism and I think understates the practical bit. Revision disputes: if you disagree with an edit a maintainer made to a page, discuss…
-
A certificate whose chromatogram axes do not match its stated method Replied, post #5 · Sourcing › Red flags · 22 Feb 2025 · 3 likes Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in short time windows raises suspicion about stability and…
-
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #24 · Practice › Interactions · 18 Feb 2025 · 2 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
What we do not know about retatrutide, listed explicitly Replied, post #85 · Compounds › Retatrutide · 6 Feb 2025 · 2 likes Worth separating two things that post #81 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Protein density versus volume when you cannot eat much Replied, post #41 · Nutrition & Training › Protein & intake · 30 Jan 2025 · 0 likes Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass is the priority. Protein comes second to total intake.
-
Canadian access and provincial variation Replied, post #14 · Regional › North America · 23 Jan 2025 · 0 likes Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access barriers. The denial letter tells you which barrier…
-
Identical chromatograms across two different lots Replied, post #80 · Sourcing › Red flags · 22 Jan 2025 · 6 likes Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is showing you something about how they operate.
-
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #3 · Clinical › Bloodwork · 19 Jan 2025 · 7 likes HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
-
Recovery when intake is low: what to cut first Replied, post #67 · Nutrition & Training › Resistance training · 13 Jan 2025 · 25 likes Maintenance is the goal: preserving lean mass and strength during weight loss is the goal of resistance training in this context, not building new muscle. That goal is…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #79 · Compounds › Semaglutide · 23 Dec 2024 · 0 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #159 · Analytics › COA interpretation · 21 Dec 2024 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: When to suspect the method rather than the sample Replied, post #103 · Analytics › Method validation · 20 Dec 2024 · 6 likes This follows post #100 rather than contradicting it. Range: the concentration range over which the method has been validated. Going outside the validated range is going…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #33 · Practice › Side effects · 29 Nov 2024 · 0 likes post #32 answers the question as asked. The question underneath it is different. Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #65 · Compounds › Tirzepatide · 26 Nov 2024 · 0 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
Fixed versus detachable needles: the trade-offs Replied, post #17 · Devices › Syringes & needles · 24 Nov 2024 · 0 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #11 · Clinical › Special populations · 19 Nov 2024 · 7 likes Picking up post #8: that is the part I would want checked first. Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes…
-
Time to steady state after a dose increase Replied, post #136 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 33 likes Coming back to post #134, because the follow-up matters more than the original answer. Renal clearance: these compounds are cleared partly via the kidney. In severe…
-
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #4 · Practice › Dosing & titration · 29 Oct 2024 · 0 likes post #3 is right about the mechanism and I think understates the practical bit. Dose equivalence between different incretin analogues is a weak concept. The molecules…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #12 · Sourcing › Regulatory · 23 Oct 2024 · 0 likes Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #69 · Clinical › Comorbidities · 20 Oct 2024 · 0 likes Picking up post #66: that is the part I would want checked first. Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index.…
-
Food noise reducing and the disorientation that can follow Replied, post #14 · Wellbeing › Mental health · 29 Sep 2024 · 6 likes Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the risk-benefit calculation. Appetite suppression might trigger relapse.…
-
Reading a supplementary appendix and finding the interesting part Started this topic · Evidence › Trials · 29 Sep 2024 · 52 likes Reading a supplementary appendix and finding the interesting part — setting out what I have, and where I think it stops being reliable. I have seen FLOW ( N Engl J Med…
-
Gallbladder disease risk with rapid weight loss Replied, post #12 · Clinical › Comorbidities · 23 Sep 2024 · 1 like PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with obesity and insulin resistance. Data on compounds in this class in PCOS specifically is…
-
Reporting a discrepancy without making an allegation Replied, post #43 · Sourcing › Vendor reports · 26 Aug 2024 · 29 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
-
Coming back to: What consumer-accessible tests can and cannot determine Started this topic · Analytics › Home & field testing · 18 Aug 2024 · 28 likes Asking directly, because I could not find a straight answer: What consumer-accessible tests can and cannot determine Posting the method first, because I know what the…
-
How this community labels and discusses unrefereed work Replied, post #98 · Evidence › Preprints · 20 Jul 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #10 · Evidence › Journal club · 8 Jul 2024 · 4 likes Worth separating two things that post #6 runs together. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped…